Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 131 - 140 of 856

Ensuring Access to Behavioral Health Care: Making Integrated Care a Reality

This is invited testimony to the U.S. Senate Finance Committee during the hearing on "Behavioral Health Care When Americans Need It: Ensuring Parity and Care Integration" about making behavioral health services accessible to Americans, including care for substance use disorders.

Format
Report/Paper/Issue Brief
Audience
Policymakers and Payers
Behavioral Health Providers
Medical Providers
Other Team Members
Organizational Leadership
Source
The Commonwealth Fund; Williams RD
Year
Resource Type
PDF

Evaluation of Mental Health Mobile Applications

This Technical Brief proposes a framework to assess mental health mobile applications, including those related to substance use, with the aim to facilitate selection of apps. The results of applying the framework will yield summary statements on the strengths and limitations of the apps and are intended for use by providers and patients/caregivers.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Agency of Healthcare Research and Quality (AHRQ)
Year
Resource Type
PDF

Fentanyl Drug Checking and Screening: Roundtable on Clinical Perspectives Summary Report

This document summarizes the discussion from the meeting of clinicians and researchers who are knowledgeable about screening for fentanyl and other drugs, primarily in health care settings. The focus of the meeting was to understand clinician/researcher perspectives about clinical fentanyl testing and distribution of fentanyl test strips (FTS) to patients and discuss next steps for technology development, research, and practice.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Reagan-Udall Foundation for the FDA (Food and Drug Administration)
Year
Resource Type
PDF

Fentanyl Drug Checking and Screening: Roundtable on Community Perspectives Summary Report

These proceedings summarize the discussion from the harm reduction community roundtable and supplemental individual interviews, inclusive of representatives from national and local harm reduction organizations, state and local government agencies, tribal organizations, and researchers who have experience distributing fentanyl test strips (FTS) or are knowledgeable about FTS specifically or drug checking more generally.

Format
Report/Paper/Issue Brief
Audience
Behavioral Health Providers
Communities
Medical Providers
Other Team Members
Source
Reagan-Udall Foundation for the FDA (Food and Drug Administration)
Year
Resource Type
PDF

Financing the Future of Integrated Care

This decision support tool and accompanying integrated care billing modules, including those related to substance use, offer guidance to provider organizations on how to finance integrated care.

Format
Toolkit
Webinar/Video
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Organizational Leadership
Practice Facilitators/Quality Improvement Coaches
Source
National Council for Mental Wellbeing
Year
Resource Type
Web Page

Food and Drug Administration Overdose Prevention Framework

The FDA Overdose Prevention Framework consists of four overarching priorities that align with the U.S. Department of Health & Human Services' Overdose Prevention Strategy to address the public health emergency as it continues to evolve.
Format
Toolkit
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Food and Drug Administration (FDA)
Year
Resource Type
PDF